CDRBY Financials 07/16/2014 20:26:08 Cardia Biopl
Post# of 3
Cardia Bioplastics, Ltd.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 4,623 4,409 1,766 1,863
Cost of Revenue 4,124 3,834 1,632 1,789
Gross Profit 499 575 133 74
Operating Expenses
Research and Development 799 1,402 1,416 810
Sales, General and Admin. 1,122 2,940 2,946 2,116
Non-Recurring Items 89 - - 1,017
Other 125 122 155 168
Operating Income (1,484) (4,002) (4,384) (4,037)
Income From Continuing Operations
Add'l Income/Expense Items (1,165) (887) 789 (389)
Earnings Before Interest and Tax (2,801) (4,776) (3,558) (4,764)
Interest Expense - - - -
Earnings Before Tax (2,801) (4,776) (3,558) (4,764)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - (299)
Net Income Cont. Operations (2,801) (4,776) (3,558) (4,764)
Non Recurring Events
Discontinued Operations - - - 73
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,801) (4,776) (3,558) (4,691)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,801) (4,776) (3,558) (4,691)